The biology of NKT cells A Bendelac, PB Savage, L Teyton Annu. Rev. Immunol. 25 (1), 297-336, 2007 | 2704 | 2007 |
Mouse CD1-specific NK1 T cells: development, specificity, and function A Bendelac, MN Rivera, SH Park, JH Roark Annual review of immunology 15 (1), 535-562, 1997 | 1667 | 1997 |
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections J Mattner, KL DeBord, N Ismail, RD Goff, C Cantu III, D Zhou, ... Nature 434 (7032), 525-529, 2005 | 1359 | 2005 |
Lysosomal glycosphingolipid recognition by NKT cells D Zhou, J Mattner, C Cantu III, N Schrantz, N Yin, Y Gao, Y Sagiv, ... Science 306 (5702), 1786-1789, 2004 | 1211 | 2004 |
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. O Lantz, A Bendelac Journal of Experimental Medicine 180 (3), 1097-1106, 1994 | 1199 | 1994 |
Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells C Carnaud, D Lee, O Donnars, SH Park, A Beavis, Y Koezuka, ... The Journal of Immunology 163 (9), 4647-4650, 1999 | 1152 | 1999 |
CD1 Recognition by Mouse NK1+ T Lymphocytes A Bendelac, O Lantz, ME Quimby, JW Yewdell, JR Bennink, ... Science 268 (5212), 863-865, 1995 | 1135 | 1995 |
A committed precursor to innate lymphoid cells MG Constantinides, BD McDonald, PA Verhoef, A Bendelac Nature 508 (7496), 397-401, 2014 | 869 | 2014 |
The transcription factor PLZF directs the effector program of the NKT cell lineage AK Savage, MG Constantinides, J Han, D Picard, E Martin, B Li, O Lantz, ... Immunity 29 (3), 391-403, 2008 | 832 | 2008 |
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. A Bendelac, C Carnaud, C Boitard, JF Bach The Journal of experimental medicine 166 (4), 823-832, 1987 | 782 | 1987 |
Distinct functional lineages of human Vα24 natural killer T cells PT Lee, K Benlagha, L Teyton, A Bendelac Journal of Experimental Medicine 195 (5), 637-641, 2002 | 763 | 2002 |
An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib–restricted α/β T cell subpopulation in mammals F Tilloy, E Treiner, SH Park, C Garcia, F Lemonnier, H De La Salle, ... The Journal of experimental medicine 189 (12), 1907-1921, 1999 | 688 | 1999 |
In vivo identification of glycolipid antigen–specific T cells using fluorescent CD1d tetramers K Benlagha, A Weiss, A Beavis, L Teyton, A Bendelac Journal of Experimental Medicine 191 (11), 1895-1904, 2000 | 687 | 2000 |
A thymic precursor to the NK T cell lineage K Benlagha, T Kyin, A Beavis, L Teyton, A Bendelac Science 296 (5567), 553-555, 2002 | 651 | 2002 |
Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. A Bendelac The Journal of experimental medicine 182 (6), 2091-2096, 1995 | 642 | 1995 |
Role of NK1. 1+ T cells in a TH2 response and in immunoglobulin E production T Yoshimoto, A Bendelac, C Watson, J Hu-Li, WE Paul Science 270 (5243), 1845-1847, 1995 | 591 | 1995 |
A subset of CD4+ thymocytes selected by MHC class I molecules A Bendelac, N Killeen, DR Littman, RH Schwartz Science 263 (5154), 1774-1778, 1994 | 587 | 1994 |
Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin A JJ Bunker, TM Flynn, JC Koval, DG Shaw, M Meisel, BD McDonald, ... Immunity 43 (3), 541-553, 2015 | 576 | 2015 |
Autoreactivity by design: innate B and T lymphocytes A Bendelac, M Bonneville, JF Kearney Nature Reviews Immunology 1 (3), 177-186, 2001 | 554 | 2001 |
Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes A Lehuen, O Lantz, L Beaudoin, V Laloux, C Carnaud, A Bendelac, ... The Journal of experimental medicine 188 (10), 1831-1839, 1998 | 482 | 1998 |